The American public deserves more COVID-19 vaccine options
Covaxin, an inactivated SARS-CoV-2 vaccine and the only vaccine to have been proven effective against all variants including the Delta variant in a Phase III clinical study, deserves to be tested in clinical trials in the U.S. for potential CDC/FDA approval for use in the U.S.
As we are about to celebrate the one-year anniversary of the vaccine rollout against COVID-19, we would do well to remember that despite the progress …







![Stopping medication requires as much skill as starting it [PODCAST]](https://kevinmd.com/wp-content/uploads/The-Podcast-by-KevinMD-WideScreen-3000-px-4-190x100.jpg)





![Weaponizing food allergies in entertainment endangers lives [PODCAST]](https://kevinmd.com/wp-content/uploads/The-Podcast-by-KevinMD-WideScreen-3000-px-3-190x100.jpg)